(VIANEWS) – The NASDAQ ended the session with TherapeuticsMD jumping 5.61% to $0.35 on Wednesday, after two sequential sessions in a row of losses. NASDAQ slid 0.27% to $14,468.42, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
Today’s last reported volume for TherapeuticsMD is 3106260, 48.78% below its average volume of 6065130.
TherapeuticsMD’s last close was $0.34, 87.81% below its 52-week high of $2.75.
TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be oversold (<=20).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.35 at 16:25 EST, below its 52-week low of $0.37.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way below its 50-day moving average of $0.66 and way below its 200-day moving average of $1.00.
More news about TherapeuticsMD (TXMD).